Yichang Central People’s Hospital was approved by yichang city’s first third generation of test-tube baby technology qualification

On May 10, hubei Provincial Health Commission approved the establishment of the reproductive Medicine Center of Yichang Central People’s Hospital to carry out preimplantation genetic diagnosis technology (PGT) (the third generation of test-tube babies).Since then, the downtown hospital has become the first unit in Yichang city to carry out the preparation of preimplantation genetic diagnosis technology (PGT).Preimplantation embryo genetic diagnosis technology is a technology that carries out relevant genetic testing on embryos before embryo transfer, removes the embryos that may carry serious genetic defects, selects healthy embryos for transplantation, and prevents the transmission of genetic diseases to offspring.It is the third generation of IVF technology in addition to the first generation of IVF — in vitro fertilization — embryo transfer (IVF-ET) and the second generation of IVF technology — intracytoplasmic sperm microinjection technology (ICSI).”The preparation of preimplantation embryo genetic diagnosis technology project fills the gap of assisted reproduction technology in yichang city. This technology will bring good news to patients with genetic diseases such as chromosome abnormality and single gene disease, and help them realize their desire to have healthy children.”Yichang Central People’s Hospital reproductive medicine center Director Ye Hong said.PGT, as an important genetic diagnosis technology, includes preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), helping couples suffering from genetic diseases to obtain healthy offspring.Hereditary diseases not only trouble families, but also cause serious family and social problems, which has been a difficult problem in the medical field.With the development of human assisted reproduction technology, especially the progress of gene testing technology, the pathogenic gene loci of many genetic diseases can be identified. PGT technology is to conduct genetic testing on the obtained embryonic cells and select the normal embryos for transplantation, so as to avoid the birth of children with serious genetic diseases.Professor Ye Hong, Second-level chief physician, master tutor, visiting scholar to THE United States The First Clinical Medical School of China Three Gorges University & AMP;Director of department of Obstetrics and Gynecology, Director of obstetrics and Gynecology, director of reproductive Center, Yichang Central People’s Hospital.Standing committee member of Gynecology and Obstetrics Branch of Chinese Endoscopy Association, Vice Chairman of Reproductive Medicine Branch of Hubei Medical Association, vice president of Hubei Female Physicians Association.The current chairman of yichang Medical Association obstetrics and Gynecology Branch, director of Yichang Obstetrics and Gynecology Quality Control Center.Yichang municipal government awarded the title of “Ye Hong Famous doctor studio” and yichang municipal government awarded the title of “city management expert”.She has rich experience in the diagnosis and treatment of gynecology and obstetrics diseases, female reproductive endocrine diseases and infertility.Good at uterine, laparoscopic surgery and a variety of assisted reproductive technology.He has led the department of obstetrics, reproductive medicine and gynecology of the hospital to win the title of “Key Clinical Specialty of Hubei Province”, and led the department to rank 48th in scientific and technological value in China in 2018.He has published more than 60 academic papers in authoritative journals at home and abroad, including many SCI papers.As the first person in charge of provincial and municipal science and technology progress awards;He has won a number of national and provincial scientific research projects, and is the chief editor of two professional works in English and Chinese.Declaration: The copyright of this article belongs to the original author, if there is a source error or infringement of your legitimate rights and interests, you can contact us through the mailbox, we will promptly deal with.Email address: jpbl@jp.jiupainews.com

Leave a Reply

Your email address will not be published.